Enovis ROE 2010-2024 | ENOV
Current and historical return on equity (ROE) values for Enovis (ENOV) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Enovis ROE - Return on Equity Historical Data |
Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
2024-09-30 |
$-0.12B |
$3.33B |
-3.59% |
2024-06-30 |
$-0.09B |
$3.29B |
-2.70% |
2024-03-31 |
$-0.08B |
$3.31B |
-2.41% |
2023-12-31 |
$-0.03B |
$3.42B |
-0.96% |
2023-09-30 |
$-0.08B |
$3.44B |
-2.18% |
2023-06-30 |
$-0.14B |
$3.45B |
-4.04% |
2023-03-31 |
$-0.05B |
$3.45B |
-1.51% |
2022-12-31 |
$-0.01B |
$3.45B |
-0.37% |
2022-09-30 |
$0.02B |
$3.41B |
0.57% |
2022-06-30 |
$0.12B |
$3.49B |
2.66% |
2022-03-31 |
$0.07B |
$4.64B |
1.49% |
2021-12-31 |
$0.07B |
$4.66B |
1.61% |
2021-09-30 |
$0.11B |
$4.63B |
2.54% |
2021-06-30 |
$0.09B |
$4.35B |
2.40% |
2021-03-31 |
$0.06B |
$4.29B |
1.55% |
2020-12-31 |
$0.04B |
$3.59B |
1.22% |
2020-09-30 |
$-0.01B |
$3.46B |
-0.23% |
2020-06-30 |
$-0.01B |
$3.40B |
-0.33% |
2020-03-31 |
$-0.47B |
$3.34B |
-14.28% |
2019-12-31 |
$-0.53B |
$3.49B |
-15.51% |
2019-09-30 |
$-0.47B |
$3.13B |
-13.67% |
2019-06-30 |
$-0.44B |
$3.26B |
-12.73% |
2019-03-31 |
$0.06B |
$3.74B |
1.77% |
2018-12-31 |
$0.14B |
$3.48B |
3.91% |
2018-09-30 |
$0.11B |
$3.48B |
2.93% |
2018-06-30 |
$0.12B |
$3.54B |
3.34% |
2018-03-31 |
$0.14B |
$3.84B |
3.79% |
2017-12-31 |
$0.15B |
$3.73B |
4.37% |
2017-09-30 |
$0.18B |
$3.51B |
5.34% |
2017-06-30 |
$0.16B |
$3.37B |
4.92% |
2017-03-31 |
$0.15B |
$3.21B |
4.59% |
2016-12-31 |
$0.13B |
$3.09B |
4.08% |
2016-09-30 |
$0.14B |
$3.17B |
4.21% |
2016-06-30 |
$0.13B |
$3.16B |
3.86% |
2016-03-31 |
$0.14B |
$3.24B |
4.17% |
2015-12-31 |
$0.17B |
$3.26B |
5.05% |
2015-09-30 |
$0.20B |
$3.30B |
6.09% |
2015-06-30 |
$0.26B |
$3.43B |
7.61% |
2015-03-31 |
$0.40B |
$3.25B |
11.52% |
2014-12-31 |
$0.37B |
$3.35B |
10.62% |
2014-09-30 |
$0.33B |
$3.54B |
9.76% |
2014-06-30 |
$0.30B |
$3.65B |
9.78% |
2014-03-31 |
$0.16B |
$3.40B |
5.87% |
2013-12-31 |
$0.16B |
$2.74B |
6.46% |
2013-09-30 |
$0.14B |
$2.57B |
6.00% |
2013-06-30 |
$0.09B |
$2.40B |
4.18% |
2013-03-31 |
$0.05B |
$2.06B |
2.16% |
2012-12-31 |
$-0.08B |
$2.16B |
-3.83% |
2012-09-30 |
$-0.11B |
$2.18B |
-6.81% |
2012-06-30 |
$-0.11B |
$2.10B |
-9.58% |
2012-03-31 |
$-0.11B |
$2.22B |
-15.27% |
2011-12-31 |
$0.01B |
$0.19B |
2.16% |
2011-09-30 |
$0.03B |
$0.25B |
12.59% |
2011-06-30 |
$0.03B |
$0.25B |
13.70% |
2011-03-31 |
$0.02B |
$0.24B |
11.10% |
2010-12-31 |
$0.02B |
$0.22B |
8.29% |
2010-09-30 |
$0.02B |
$0.23B |
7.31% |
2010-06-30 |
$0.02B |
$0.19B |
7.58% |
2010-03-31 |
$0.02B |
$0.19B |
8.61% |
2009-12-31 |
$0.02B |
$0.22B |
12.53% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Information Systems |
$2.646B |
$1.707B |
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
|